Cargando…
LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression
HCC is one of the most common malignant tumors worldwide. Although traditional treatment methods have been improved in recent years, the survival rate of HCC patients has not been significantly improved. Immunotherapy has shown extremely high clinical value in a variety of tumors. In this study, we...
Autores principales: | Wu, Rongshou, Liu, Weiwei, Yang, Qingping, Zhang, Jingling, Hou, Ping, Xiong, Jianghui, Wu, Linquan, Li, Enliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562488/ https://www.ncbi.nlm.nih.gov/pubmed/37813900 http://dx.doi.org/10.1038/s41598-023-42948-8 |
Ejemplares similares
-
The regulatory role and mechanism of lncTUG1 on cartilage apoptosis and inflammation in osteoarthritis
por: Liu, Nan-nan, et al.
Publicado: (2023) -
TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a
por: Liu, Weiwei, et al.
Publicado: (2021) -
LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway
por: Chen, Weixi, et al.
Publicado: (2023) -
lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET
por: Wang, Pan, et al.
Publicado: (2020) -
LncTUG1 ameliorates renal tubular fibrosis in experimental diabetic nephropathy through the miR-145-5p/dual-specificity phosphatase 6 axis
por: Wang, Taoxia, et al.
Publicado: (2023)